Neurogene shares reached a 52-week high after the genetic medicine company announced an oversubscribed private placement of about $200 million. The stock was up 44% to $66.55 on Monday, with an ...

The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett ...

The company will use the funds to enroll a registrational trial for its investigational gene therapy NGN-401 for Rett Syndrome.

The man who acquired Sound United and founded US Health Company Masimo has been sacked by his own board, and to top that that ...

Fintel reports that on November 1, 2024, Jones Trading downgraded their outlook for ESSA Pharma (NasdaqCM:EPIX) from Buy to ...

OpenAI led the way last month and it really wasn’t even close. However, there were lots of other big raises — as a startup had to raise more than $200 million to make October’s list as investors were ...

American venture capitalists are increasingly building U.S.-based companies from scratch to commercialize drugs developed in ...

GlycoMimetics (GLYC) announced it has entered into an acquisition agreement with Crescent Biopharma, a privately held biotechnology company.

Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of ...

Masimo Corp. is suing founder Joe Kiani—who lost a takeover fight last month against Politan Capital Management LP—saying he ...

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. How Trustnet’s fund picks can beat the MSCI Wo ...

The boom experienced by the weight loss drug market comes as little surprise when considering that almost a third of the ...